Decisionmaking, independence and integrity
Evaluation requires a firm sense of what is relevant to patients, what doctors believe is important, and how medical practice is developing.
In order to ensure access to the best expertise, MEB assessors constantly interact with actors in medical practice, and some also work in academic hospitals. When performing these tasks, it is essential to safeguard the expertise, independence and integrity of MEB Board members, MEB staff and external experts. Additionally, good governance requires clarity regarding formulation and implementation of MEB decisions, and supervision of the MEB and its funding.
MEB Board members are active participants in daily clinical, pharmacological or scientific practice. They represent a broad range of specialities that play a key role in the choices and decision-making surrounding medicines, such as family medicine, internal medicine, (hospital) pharmacy and toxicology. Specialists focused on the rights of specific groups of patients, such as geriatrists, are also represented.
Pursuant to the Medicines Act, the MEB consists of no more than 17 people. MEB Board members are appointed by the Minister of Health, Welfare and Sport. Appointments are for a term of 4 years, and reappointment is possible. Striking a healthy balance between safeguarding scarce, specialised and independent expertise and stimulating innovation is very important for the functioning of the MEB. The minimum term for an effective MEB membership is two 4-year periods, and the ideal term for a nomination is three 4-year periods.